You are here

cancer

Blocking PD-L1 production in mice, UCSF team spotlights preclinical promise of a Pfizer-partnered I/O drug

Endpoints

Thu, 01/17/19 - 12:01 am

immuno-oncology

In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for Imbruvica

Endpoints

Tue, 01/15/19 - 10:08 am

Liquid biopsy-based system could prevent cancer from spreading

Pharmaforum

Fri, 01/11/19 - 09:48 am

metastic cancer

Black Diamond Gets $85M for Cancer Drugs R&D and New Cambridge HQ

Xconomy

Thu, 01/10/19 - 09:45 am

Black Diamond Therapeutics

For CAR-T Cancer Fighters in the Real World, Two Roads Diverge

Xconomy

Thu, 01/3/19 - 04:16 pm

Gilead Sciences

New Clinical Trial Aims To Detect Cancer With A Quick Breathalyser Test

Forbes

Thu, 01/3/19 - 09:48 am

clinical trials

Owlstone Medical

Pharma's 2019 Prognosis Hinges on These Key Themes

Bloomberg

Wed, 01/2/19 - 09:48 pm

Deciphera expands cancer trial after seeing early data

Fierce Biotech

Wed, 01/2/19 - 11:13 am

clinical trials

Five Things To Look Out For In Cancer Research In 2019

Forbes

Mon, 12/31/18 - 12:06 pm

Relay Therapeutics Banks $400 Million in Series C Round

CP Wire

Thu, 12/20/18 - 10:03 am

Relay Therapeutics

Syntropy, a Merck KGaA – Palantir JV aiming to apply big data to cancer research

GoinPharma

Sun, 11/25/18 - 08:02 pm

Palantir Technologies

Merck KGaA Enters Field of Big Data With Joint Venture With Palantir Technologies

BioSpace

Tue, 11/20/18 - 11:50 am

Palantir Technologies

Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years

BioSpace

Mon, 11/19/18 - 11:29 am

Ariad Pharmaceuticals

Boehringer Ingelheim

Bristol-Myers Squibb

Puma Biotechnology

Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million Upfront and $280 Million in Biobucks

BioSpace

Thu, 11/15/18 - 10:46 am

drug development

Boehringer Ingelheim

Viagra and Cialis: PDE-5 Inhibitors May Have Broader Applications in Cancer, Neurology and Cardiovascular Health

BioSpace

Wed, 11/14/18 - 09:56 am

erectile dysfunction

drug repurposing

A $3 Billion Startup's Shares Gain On Hopes For A Cancer Blood Test

Forbes

Mon, 11/12/18 - 11:39 pm

Guardant Health

‘We ran out of money’: High-profile startup seeking to connect patients with clinical trials shuts down

Stat

Mon, 11/12/18 - 09:25 am

clinical trials

GSK’s systemic STING agonist could overcome delivery hurdles

BioCentury

Wed, 11/7/18 - 07:15 pm

Which media reaches cancer patients? Depends on their diagnosis: report

Fierce Pharma

Wed, 11/7/18 - 10:37 am

How A Small Scottish Biotech Firm Could Win A Decisive Battle Against Cancer

Forbes

Mon, 10/29/18 - 09:44 am

drug development

Pages